US$ 26.62
glp-1 agonists vision loss blindness Ocular Effects of Receptor Agonists: A Review of Current Evidence and Safety Concerns Investigating Vision Changes Linked to
Description
Clinical efficacy of once-weekly glucagonlike peptide-1 receptor agonists in patients with type 2 diabetes

[DOI] [PubMed] [Google Scholar] 156.Webb G.C., Akbar M.S., Zhao C., Swift H.H., Steiner D.F

10.2337/db08-0958

Twarog C, Fattah S, Heade J, Maher S, Fattal E, Brayden DJ

Antihyperglycemic and Antioxidative Potential of Matricaria Chamomilla L

H., Brown-Frandsen, K., et al
